US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% WDC $415.29 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Simulations Plus, Inc. - Common Stock (NQ:SLP)

18.50 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Simulations Plus, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements ↗
Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing... 
Via Benzinga
Topics Animal Testing
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet ↗
 
Via Benzinga
News headline image
Simulations Plus Posts Better-Than-Expected Results, Joins Savers Value Village, MarketAxess Holdings And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Simulations Plus Q1 Earnings Assessment ↗
 
Via Benzinga
News headline image
What to Expect from Simulations Plus's Earnings ↗
 
Via Benzinga
News headline image
Breaking Down Simulations Plus: 2 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
US Stocks Likely To Open Lower After The Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert ↗
U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs. 
Via Benzinga
Topics Government
News headline image
Guess, Simulations Plus And 3 Stocks To Watch Heading Into Friday ↗
 
Via Benzinga
News headline image
Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Earnings Scheduled For April 3, 2025 ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Are Set To Fly This Month ↗
 
Via Benzinga
News headline image
Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Earnings Scheduled For January 7, 2025 ↗
 
Via Benzinga
News headline image
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in the BTIG Digital Health Forum
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in the Stephens Annual Investment Conference
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Releases DILIsym® X
From Simulations Plus, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >